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PRRSV  is a positive-sense  RNA  virus  with  a high  degree  of  genetic  variability  among  isolates.  For  diagnos-
tic  sensitivity  and vaccine  design  it is  essential  to  monitor  PRRSV  genetic  diversity.  However,  to  date  only
a  few  full  genome  sequences  of PRRSV  isolates  have  been  made  publicly  available.  In the  present  study,
fast  and  robust  methods  for  long  range  RT-PCR  ampliﬁcation  and  subsequent  next generation  sequenc-
ing  (NGS)  were  developed  and  validated  on  nine  Type  1 and nine  Type  2 PRRSV  viruses.  The  methods
generated  robust  and  reliable  sequences  both  on  primary  material  and  cell  culture  adapted  viruses andeywords:
RRSV
ull genome sequencing
ext generation sequencing
llumina HiSeq2000
oche 454 FLX
the protocols  performed  well  on  all  three  NGS  platforms  tested  (Roche  454  FLX,  Illumina  HiSeq2000,  and
Ion Torrent  PGMTM Sequencer).  These  methods  will  greatly  facilitate  the  generation  of more  full  genome
PRRSV  sequences  globally.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.on Torrent PGM sequencer
. Introduction
Porcine Reproductive and Respiratory Syndrome (PRRS), a
otent viral disease of pigs, has a major impact on the health and
elfare of pigs throughout the world. PRRSV causes reproductive
ailures in sows and gilts and respiratory diseases in growing pigs
Collins et al., 1992; Terpstra et al., 1991; Wensvoort et al., 1991).
ifferent PRRSV strains have been claimed to differ in virulence, but
he underlining molecular determinants are still unknown despite
ecades of research.PRRS virus belongs to the Arteriviridae family, within the order
idovirales (Cavanagh, 1997). It is a small enveloped virus contain-
ng a positive-sense single-stranded RNA genome with a 5′ cap and
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Open access under CC BY-NC-NDa polyadenylated 3′-end (Benﬁeld et al., 1992; Meulenberg et al.,
1998). The genome is 15–15.5 kb in length and encodes 10 ORFs
including the recently discovered ORF5a (Firth et al., 2011; Johnson
et al., 2011; Snijder and Meulenberg, 1998; Wu et al., 2001). Based
on nucleotide sequence comparison of European and North Ameri-
can isolates, PRRSV is divided into two genotypes, Type 1 and Type
2 respectively, with only 50–60% nucleotide identity (Allende et al.,
1999). Furthermore, Type 1 PRRSV genotype has been found to be
more diverse, and can be categorized into at least four subtypes,
where the protogenotype 1, the Lelystad virus (Genbank: M96262),
belongs to subtype 1 (Stadejek et al., 2002, 2006, 2008).
Most of the molecular analyses of the PRRSV genome have been
performed on the genes coding for the structural proteins (ORF2-7)
only. Of the seven structural proteins, glycoprotein 5 (GP5) encoded
by ORF5 and the nucleocapsid (N) protein encoded by ORF7 have
been the most examined. GP5 has been shown to contain a B-cell
neutralizing epitope and is regarded as the most immunogenic
viral protein, whereas the N protein has shown size polymorphism
(Ansari et al., 2006; Oleksiewicz et al., 2002; Ostrowski et al., 2002;
Stadejek et al., 2002). Previous reports suggested that the length
of ORF7 could be used as a subtype maker since its length varied
between Type 1 strains originating from Eastern Europe (Stadejek
et al., 2002, 2006, 2008). However, recently a PRRSV isolate from
Slovakia encoded a 132 amino acid N protein (compared to 128
 license.
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Table  1
Overview of sample origin and material.
Virus sample Year of isolation Genotype Material Origin
DK-1992-PRRS-111 92 1992 Type 1 PAM isolate Denmark
DK-2010-10-10-3 2010 Type 1 PAM isolate Denmark
DK-2011-05-11-14 2011 Type 1 PAM isolate Denmark
DK-2011-05-23-9 2011 Type 1 PAM isolate Denmark
ESP-1991-Olot91 1991 Type 1 Marc-145 isolate Spain
DK-2003-6-5 2003 Type 1 PAM isolate Denmark
DK-2003-7-2 2003 Type 1 PAM isolate Denmark
DK-2008-10-5-2 2008 Type 1 Lung homogenate Denmark
DK-2012-01-05-2 2012 Type 1 Serum Denmark
DK-2010-10-1-2 2010 Type 2 Lung homogenate Denmark
DK-2003-2-3 2003 Type 2 Marc-145 isolate Denmark
DK-2004-2-1 2004 Type 2 Marc-145 isolate Denmark
DK-2008-10-1-3 2008 Type 2 Lung homogenate Denmark
DK-2012-01-11-3 2012 Type 2 Lung homogenate Denmark
DK-2010-10-4-1 2010 Type 2 Lung homogenate Denmark
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3DK-1997-19407B 1997 
DK-2004-1-7-Pl 2004 
DK-2011-030311-1 2011 
mino acids N protein in the Lelystad virus), but otherwise resem-
led the subtype 1 PRRSV (Jackova et al., 2012). These ﬁndings
mphasized that the diversity of PRRSV are more complex than
nitially anticipated and that examination of small genetic regions
s not sufﬁcient for understanding PRRSV sequence heterogeneity.
his is further supported by the emergence of a highly pathogenic
train of PRRSV in China in 2006, which was highly similar to other
ype 2 PRRSV strains in ORF5 and ORF7, but had indeed unique fea-
ure differences in other genes (An et al., 2010; Tian et al., 2007).
ntil now, only few full genome sequences of European PRRSV
solates have been characterized (Darwich et al., 2011) and sim-
larly little is known on the diversity of European Type 2 strains
irculating in Europe. To accelerate the generation of full genome
equences of PRRSV, application of next generation sequencing
NGS) technology is the method of choice. In recent years the cost
f using this technology has been reduced substantially and hereby
aking it more accessible (Glenn, 2011). The aim of the present
tudy was to develop and validate a method for robust and reliable
ull length sequencing of PRRSV Type 1 and 2 based on long range
CR performed on viral RNA extracted from both primary material
nd cell culture isolates.
. Material and methods
.1. Sample material
Samples included in this study were collected in Danish pig
arms during the years 1992–2012. Details on the viruses and their
rigin are listed in Table 1. Some of the viruses were proliferated
n Marc-145 cells or porcine alveolar macrophages (PAM) follow-
ng the general procedure (Kim et al., 1993; Wensvoort et al., 1991).
he ESP-1991-Olot91 “third passage MA-104” isolate was obtained
rom Dr. Luis Enjuanes (Department of Molecular and Cell Biology,
SIC, Madrid, Spain). One further passage in Marc-145 was  carried
ut prior to sequencing.
.2. Viral RNA puriﬁcation
Viral RNA was puriﬁed from serum, lung tissues or cell cul-
ure supernatants. Lung tissue was prepared as a 5% homogenate
n RLT buffer (RNeasy® Mini Kit, QIAGEN, cat. no. 74106) with
% -mercaptoethanol (Sigma–Aldrich, cat. no. M3148). One steel
ead (QIAGEN, cat. no. 69989) was added to each sample and the
amples were homogenized in a Tissuelyser II (QIAGEN, cat. no.
5300) for 3 min  at 30 Hz. The homogenate was centrifuged for
 min  at 12,000 × g 600 l lung tissue homogenate was  mixed withpe 2 Marc-145 isolate Denmark
pe 2 Marc-145 isolate Denmark
pe 2 Lung homogenate Denmark
an equal volume of 70% ethanol by pipetting and then transferred
to an RNeasy® Mini column. The rest of the puriﬁcation procedure
was performed as described by the manufacturer’s instructions for
puriﬁcation of total RNA from animal tissues with RNeasy Mini Kit
(QIAGEN). RNA from serum and cell culture supernatant was puri-
ﬁed using QIAamp® Viral RNA Mini Kit (QIAGEN, cat. no. 52906)
using the conditions recommended by the manufacturer. The RNA
was stored at −80 ◦C until use.
2.3. Screening for PRRSV with real-time RT-PCR
PRRSV positive samples we  selected for sequencing by screening
of puriﬁed RNA using a modiﬁcation of the Primer Probe Energy
Transfer RT-PCR (PriProET-RT-PCR) OneStep real-time RT-PCR
assay previously described (Balka et al., 2009).
2.4. cDNA synthesis
Full-length cDNA synthesis was performed with SuperScript® III
First-Strand Synthesis System (Invitrogen, cat. no. 18080-51) using
3′-end poly(dT) reverse transcription (RT)-primer: 5′-CAG GAA ACA
GCT ATG ACA CCT GAT CTC TAG AAA CGT T(T)38-3′ (Nielsen et al.,
2003). The method for the synthesis of full-length cDNA was as pre-
viously described for pestiviruses (Rasmussen et al., 2008, 2010).
In short, 8 l of puriﬁed RNA (approx. 0.7 g) was mixed with 1 l
of 10 M RT-primer and 1 l of 10 nM dNTPs. The mixture was
incubated for 5 min  at 65 ◦C in a thermal cycler with heated lid
and then placed on ice for at least 1 min. A second mixture con-
taining 2 l 10× RT buffer, 4 l 25 mM MgCl2, 2 l 0.1 M DTT, 1 l
40 U/l  RNaseOUTTM, and1 l SuperScript III RTTM was prepared
and mixed gently with the RNA/primer mixture. The cDNA syn-
thesis was  performed in a thermal cycler with heated lid at 50 ◦C
for 90 min  followed by incubation for 5 min  at 85 ◦C to inactivate
the reverse transcriptase. To collect the samples a brief centrifu-
gation step was applied and the cDNA was  treated with 1 l of
2 U/l  Escherichia coli RNase H for 20 min  at 37 ◦C to remove the
RNA template. The cDNA was stored at −20 ◦C until use.
2.5. Primers for long range PCR ampliﬁcation
All the primer sequences used for long range PCR ampliﬁ-
cation are listed in Table 2. Each primer sequence was  aligned
against the sequence of the two PRRSV proto-genotypes, Lelystad
virus (M96262) or VR2332 (U87392.3) using CLC Main Workbench
v.6.6.2 (CLC BIO, Aarhus, Denmark). The primer sequences were
adjusted to match the sequence of the two proto-genotype strains.
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Table  2
Primer sequences for long range PCR ampliﬁcation and expected amplicon sizes.
Primer name Primer sequence (5′–3′) Expected size (bp)
Type 1 PRRSV
Fragment-1-EU 7278
5′-UTR-1-35-EU-Fwa GGC GCG CCT AAT ACG ACT CAC TAT AGA TGA TGT GTA GGG TAT TCC CCC TAC ATA CAC GAC A
ORF1-7278-EU-Revb CAG CTT CAA GGC AGT TGT CA
Fragment-2-EU 8178
ORF1-6920-EU-Fwc CCC CTC TTT TTG AGA ATG GT
Poly(dT)-RTd CAG GAA ACA GCT ATG ACA CCT GAT CTC TAG AAA CGT T(T)38
Fragment A-EU 3019
5′-UTR-1-35-EU-Fwa GGC GCG CCT AAT ACG ACT CAC TAT AGA TGA TGT GTA GGG TAT TCC CCC TAC ATA CAC GAC
ORF1-3019-EU-Reva CGC GGG CGC TTG AGT TCG GCA AAT T
Fragment B-EU 4529
ORF1-2749-EU-Fwe CCT GGA CCA GCC TTT AAA TC
ORF1-7278-EU-Revb CAG CTT CAA GGC AGT TGT CA
Fragment C-EU 5500
ORF1-6920-EU-Fwc CCC CTC TTT TTG AGA ATG GT
ORF2-EU-Revf GCA CAC TGA TGA GCC ATT GT
Fragment D-EU
ORF2-EU-Fwf CTG GCA CAG AAT TGC AGG TA 3375
Poly(dT)-RTd CAG GAA ACA GCT ATG ACA CCT GAT CTC TAG AAA CGT T(T)38
Type 2 PRRSV
Fragment-1-US
Fragment-A-US-Fwg GGA GGG CCA AGT CTA CTG CAC ACG A 7588
Fragment-B-US-Revd TGG TTG TGC TCA ACC GCG T
Fragment-2-US: 7939
Fragment-C-US-Fwd TCT CAG AGT TGG CGA CCC T
Poly(dT)-RTd CAG GAA ACA GCT ATG ACA CCT GAT CTC TAG AAA CGT T(T)38
Fragment-A-US 4541/4811
Fragment-A-1-35-US-Fw CTCGAGGGCGCGCCTAATACGACTCACTATAGGATGA
CGTATAGGTGTTGGCTCTATGCCTTGGCATT
Fragment-A-US-Fwg GGA GGG CCA AGT CTA CTG CAC ACG A
Fragment-A-US-Revd GTG TCA GGG TCA ACC ACG A
Fragment-B-US 3506
Fragment-B-US-Fwd ATC TTG GCT GGA GCT TAC GT
Fragment-B-US-Revd TGG TTG TGC TCA ACC GCG T
Fragment-C-US 5500
Fragment-C-US-Fwd TCT CAG AGT TGG CGA CCC T
Fragment-C-US-Revd ATC CTG CAC CAA AGA GAC CT
Fragment-D-US 2900
Fragment-D-US-Fwd TTT CAG CAT CTA GCC GCC A
Poly(dT)-RTd CAG GAA ACA GCT ATG ACA CCT GAT CTC TAG AAA CGT T(T)38
Fw,  forward primer, Rev, reverse primer.
a Modiﬁed from Fang et al. (2006).
b Fang et al. (2006).
c Darwich et al. (2011).
d Nielsen et al. (2003).
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f Diaz et al. (2006).
g Nielsen et al. (2003).
.6. Long range PCR ampliﬁcation for sequencing
PCR ampliﬁcations were performed with AccuPrimeTM Taq DNA
olymerase High Fidelity (Invitrogen, Cat. no. 12346-086). For
mpliﬁcation of PCR products covering the PRRSV genome in
 fragments, 2 l of cDNA template was mixed with 5 l 10×
ccuPrimeTM PCR buffer I, 1 l 10 M speciﬁc forward primer
Table 2), 1 l 10 M speciﬁc reverse primer (Table 2), 0.5 l
ccuPrimeTM Taq DNA Polymerase High Fidelity, and nuclease free
ater (AMRESCO®, cat. no. E476) in a ﬁnal reaction volume of 50 l.
or ampliﬁcation of PCR products covering the PRRSV genome in 2
ragments, 1 l of AccuPrimeTM Taq DNA Polymerase High Fidelity
as used. The PCR ampliﬁcation was carried out in a T3 Thermo-
ycler (Biometra) under the following conditions: 94 ◦C 15 s [45
ycles: 94 ◦C for 15 s, 55 ◦C for 30 s, and 68 ◦C for 60 s per kb ampli-
cation], 68 ◦C for 2 min  per kb ampliﬁcation, hold at 4 ◦C. The PCRproducts were analyzed by agarose gel electrophoresis using E-gel®
0.8% agarose gels (Invitrogen, cat. no G501808). Five microliters of
PCR product mixed with 7 l 1:40 TrackItTM loading buffer (Invi-
trogen, cat no. 10482-028) were loaded onto the gel. 10 l 1 kb Plus
DNA ladder as marker (Invitrogen, cat. no. 10787-018) was used as
size marker. To remove primers and buffers, the PCR products were
puriﬁed using Roche’s High Pure PCR Product Puriﬁcation kit (cat.
no. 11 732 676 001) following the manufacturer’s protocol, with
the exception that elution was done in 30 l nuclease free water
(Amresco, cat. no. E476).
2.7. Full genome sequencingThree different platforms were used for next generation
sequencing. For the sequencing of PCR amplicons covering the full
genome of PRRSV in two fragments, 2.7 g in total of equimolar
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rag-A-EU, Frag-B-EU, Frag-C-EU, and Frag-D-EU. (B) PCR amplicons for Type 2 PRRS
nd  Frag-D-US.
oncentration was sent to LGC Genomics GmbH (Berlin, Germany)
or sequencing on the platform Roche 454 FLX. The two samples
ere sequenced at separate occasions on a 1/16 Roche/454 Pico
iter Plate pooled together with 10 and 11 other libraries prepared
rom PCR amplicons of another virus with approximately the same
ize. The sequencing of PCR amplicons covering the PRRSV genome
n four fragments was performed on the Illumina® HiSeq2000 and
on Torrent PGMTM sequencer platforms. The four PCR products
epresenting one PRRSV genome were pooled in equimolar quan-
ities to a ﬁnal amount of 1 g. The sequencing on the platform
on Torrent PGMTM sequencer was carried out by the DTU in-
ouse facility (DTU Multi-Assay Core (DMAC), Technical University
f Denmark). An Ion Torrent PGMTM chip 316 was used for 32
ibraries of approximately the same size. Sequencing on Illumina®
iSeq2000 took place at ARK Genomics (The Roslin Institute, Uni-
ersity of Edinburgh, Scotland, UK). A total of 22 libraries of the
ame genome size were pooled and sequenced on one channel ﬂow
ell. The preparation of these libraries was performed following the
llumina® TruSeqTM DNA Sample Preparation v2 Kit A and B with
inor exceptions (Illumina®, cat. no. FC-121-2001-1 and FC-121-
002). Instead of purifying the samples using Agencourt AMPure
P beads as stated in the manufactures protocol, column puriﬁca-
ions was performed using MinElute PCR Puriﬁcation Kit (QIAGEN,
at. no. 28004).
.8. 5′-RACE
For Type 2 viruses ampliﬁed using the forward primer
Fragment-A-US-FW’ (Table 2), the 5′ end nucleotides were not
mpliﬁed and therefore 5′ Rapid Ampliﬁcation of the cDNA Ends
as performed to complete the sequences. This was  performed
sing 5′ RACE System for Rapid Ampliﬁcation of cDNA Ends, ver-
ion 2.0 (Invitrogen, cat. no. 18374-058) according to instructions
rom the manufacturer. In short, one gene-speciﬁc RT-primer was
esigned for the cDNA synthesis, one for the ﬁrst PCR ampliﬁca-
ion and one for the ﬁnal nested PCR using Primer3Plus web  utility
Untergasser et al., 2007). The nested PCR products of approx-
mately 500 bp were puriﬁed directly from the reactions using
oche’s High Pure PCR Product Puriﬁcation kit (Roche, cat. no. 11
32 676 001) or they were excised from E-gel 0.8% agarose gels
nd extracted using MinElute Gel Extraction Kit (QIAGEN, cat. no.
8604). The ﬁnal RACE products were cloned into pCR®4-TOPO®
ectors and transformed into E. coli One Shot® TOP10 compe-
ent cells following the protocol for TOPO® TA Cloning® Kit formplicons for Type 1 PRRSV. Lanes 4 and 5: Frag-1-EU and Frag-2-EU, lanes 7–10:
es 4 and 5: Frag-1-US and Frag-2-US, lanes 7–10: Frag-A-US, Frag-B-US, Frag-C-US,
Sequencing (Invitrogen, K4575-02). Sequences were obtained with
cycle sequencing performed at LGC Genomics using M13  primers.
2.9. Sequence data analysis
After initial removal of adaptors and low quality sequences, the
quality of the FastQC ﬁles was examined using the applicant FastQC
(version 0.10.1). The reads were trimmed in regards to the FastQC
report. Trimming was  done by the Prinseq-lite tool and mapping of
the reads was  performed by the Burrows–Wheeler aligner (BWA)
using the Aln algorithm for the Illumina® HiSeq2000 data and
the bwasw algorithm for Roche 454 FLX and Ion Torrent PGMTM
sequencer data. Coverage depth was calculated by a combination
of Samtools and Bedtools.
The full length nucleotide sequences were aligned using
MUSCLE (MUltiple Sequence Comparison by Log-Expectation).
Phylogenetic trees of nucleotide sequences were constructed using
Maximum Likelihood Phylogeny with the following parameter sett-
ings: Starting tree: Neighbor Joining, Substitution model: HKY,
Transition/transversion ratio = 2.0, Rate variation: none, Estimate
substitution rate parameter(s) = yes, Estimate topology = yes. All
the phylogenetic analyses were carried out using CLC Main Work-
bench v.6.6.2 (CLC BIO, Aarhus, Denmark).
3. Results
3.1. Speciﬁcity of the PCR products
The long range PCR amplicons generated in this study cov-
ered the complete PRRSV genome in two or four fragments, with
sequence overlap of 270–677 bp between the fragments (Table 2).
To conﬁrm the size, the puriﬁed PCR products were run on a 0.8%
agarose gel (Fig. 1). Most of the PCRs produced a single amplicon
with the expected size, however, in few cases an unspeciﬁc band
was in excess (Fig. 1, panel A, lane 4). In other cases, the PCR product
of interest appeared in equal amount as unspeciﬁc products (Fig. 1,
panel B, lane 9). In those cases with ambiguous products, the PCR
amplicon of interest was  gel extracted prior to sequencing.
3.2. Sequence quality and trimmingTo evaluate the quality of the NGS data, adaptors and low
quality sequences were ﬁrst removed prior to further analysis
with the FastQC application. This application helped visualize the
quality of the reads by examining different parameters such as
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Fig. 2. Box plots of Phred quality scores generated by FastQC. The gray box plots (box: interquartile ranges 25–75%, whiskers: 10–90%, and dark bar inside box: median)
show  the nucleotide-calling Phred quality score across all reads. (A) DK-PRRS-111 92 (Roche 454 FLX), (B) DK-2010-10-1-2 (Roche 454 FLX), (C) DK-2011-05-11-14 (Illumina
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tiSeq 2000), (D) Olot91(Illumina HiSeq 2000), (E) DK-2011-10-4-1 (Ion Torrent PG
he distribution of the nucleotides in each read, read lengths, and
alculated the Phred Quality Score of each nucleotide in each read.
he Phred Quality Score described the probability of incorrect base
alls and allowed to compare the efﬁcacy of the different sequenc-
ng platforms. A Phred Quality Score of 30 (Q30) is equivalent to the
robability of an incorrect base call in 1 out of a 1000 times, which
ives the base-call accuracy of 99.9% (http://www.illumina.com/
ocuments/%5Cproducts%5Ctechnotes%5Ctechnote Q-Scores.pdf).
 box plot of the Phred Quality Score distribution is shown in Fig. 2
nd in supplementary material Fig. 1. The FastQC report obtained
or Roche 454 FLX sequencing showed a decline in 3′ end reads
uality and thus the major read lengths were trimmed from 592 bp
o 450 bp. The box plot of the Phred Quality Score distribution is
hown in Fig. 2(A) and (B). The average Phred Quality Score of
he HiSeq2000 Illumina data was Q36.5 and which was highlyequencer), and (F) DK-2012-01-05-2 (Ion Torrent PGMTM Sequencer).
acceptable. Although, a small decrease in the Phred Quality Score
was observed at the 5′ end of the reads (Fig. 2, panels C and D,
and supplementary Fig. 1(A) and (B)), the mean Q values were still
above Q30, thus there was no reason for further trimming of these
data. The majority of the full genome sequences of PRRSV were
generated using the Ion Torrent PGM sequencer. The analysis of
these data by FastQC showed “warnings” in both the 5′ and 3′ ends
of the reads with regard to the distribution of the four nucleotides.
Thus, the reads were trimmed to a major length distribution of
170 bp to reach a minimal Phred Quality Score of Q20 for both
the 5′ and 3′ ends. This strategy resulted in a mean Phred Quality
Score of Q24 or Q25 (Fig. 2, panels E and F and Supplementary Fig.
1(C)–(L)), which gave an acceptable base call accuracy between
99% and 99.9%. An overview of the average Phred Quality Scores
and major read lengths is listed in Table 3.
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Table  3
Read quality and output yield.
Virus sample Platform No. of PCR fragments
for sequencing
Avg. Phred
Quality Score
Major read
length (bp)
Total readsa Mapped
reads
Mapped
reads %
Bases
mapped
DK-PRRS-111 92 FLX 2 37 450 5679 5633 99.2 2,534,850
DK-2010-10-1-2 FLX 2 29 450 13,696 13,504 98.6 6,076,800
DK-2010-10-10-3 Illumina 4 36,5b 37 3,151,310c 2,691,058b 85.4 99,569,146
DK-2011-05-11-14 Illumina 4 36,5b 37 5,560,952c 5,409,041b 97.3 200,134,517
DK-2011-05-23-9 Illumina 4 36,5b 37 4,810,154c 1,145,373b 23.8 42,378,801
ESP-1992-Olot91 Illumina 4 36,5b 37 3,792,606c 3,252,661b 85.8 120,348,457
DK-2003-6-5 Ion Torrent 4 24 170 70,875 55,844 78.8 9,493,480
DK-2003-7-2 Ion Torrent 4 24 170 63,656 32,276 50.7 5,486,920
DK-2008-10-5-2 Ion Torrent 4 24 170 75,357 51,011 67.7 8,671,870
DK-2012-01-05-2 Ion Torrent 4 25 170 55,378 50,193 90.61 8,532,810
DK-2003-2-3 Ion Torrent 4 24 170 43,915 38,252 87.1 6,502,840
DK-2004-2-1 Ion Torrent 4 25 170 41,549 36,998 89.0 6,289,660
DK-2008-10-1-3 Ion Torrent 4 24 170 74,948 55,303 73.8 9,401,510
DK-2012-01-11-3 Ion Torrent 4 25 170 77,893 30,033 38.5 5,105,610
DK-2010-10-4-1 Ion Torrent 4 24 170 52,658 41,554 78.9 7,064,180
DK-1997-19407B Ion Torrent 4 24 170 56,171 53,026 94.4 9,014,420
DK-2004-1-7-Pl Ion Torrent 4 24 170 65,900 62,542 94.9 10,632,140
DK-2011-030311-1 Ion Torrent 4 24 170 85,327 66,526 78.0 11,309,420
a After removal of adaptor and low quality sequences and examination by FastQC.
b For Illumina the average Phred Quality Score is a mean value of the Pred quality score of R1 and R2.
c Paired end reads.
Fig. 3. Depth of coverage plot. The x-axes represent the coverage of every single nucleotide position in respect to the reference sequence and the y-axes represent the
sequence depth of every single nucleotide. (A) DK-PRRS-111 92, Roche 454 FLX, (B) DK-2010-10-1-2, Roche 454 FLX, (C) DK-2011-05-11-14, Illumina HiSeq 2000, (D) Olot91,
Illumina HiSeq 2000, (E) DK-2011-10-4-1, Ion Torrent PGMTM Sequencer, and (F) DK-2012-01-05-2, Ion Torrent PGMTM Sequencer.
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Supplementary data associated with this article can be found,
n the online version, at http://dx.doi.org/10.1016/j.jviromet.
013.07.019.
.3. Sequence output and coverage
The data output varied among the different NGS platforms used,
ith the highest yield for the Illumina HiSeq2000 platform. In
able 3, total reads and mapped reads are listed for all samples. The
mount of mapped reads in percent ranged from 23.8% to 99.2%. The
utcome of mapped reads below 40% may  be result of low purity
f the PCR amplicons in the sample or low quality of the library
reparation. The distribution of the mapped reads throughout the
enomes is shown in Fig. 3 and supplementary material Fig. 2 as
 depth-of-coverage graph. Peaks with a substantially larger depth
f coverage are present in all graphs. These peaks correspond to
he overlap in sequence of the PCR amplicons. Variations in the
overage depths were seen between the PCR amplicons from the
ame sample, which indicate different quality and purity of the PCR
mplicons or imprecise preparation of equimolar pools. In some
ases regions without coverage was observed (Fig. 3) by that indi-
ating gaps compared to the reference sequence. The presence of
aps were either conﬁrmed or rejected by cycle sequencing.ype 2 PRRSV viruses. Scale bar represents 3 nucleotide changes per hundred.
Supplementary data associated with this article can be found,
in the online version, at http://dx.doi.org/10.1016/j.jviromet.
2013.07.019.
The complete full genome sequences had the lengths of
14,876–15,098 and 15,342–15,408 nucleotides, for the Type 1 and
Type 2 viruses, respectively (excluding the poly(A)-tail). Phyloge-
netic trees of the obtained full length sequences are shown in Fig. 4.
The clustering of the viruses in the trees based on the full genome
sequences was as expected and resembled the clustering of the iso-
lates when the tree was based on ORF5 sequences only (data not
shown).
4. Discussion
The main focus of this study was to develop fast and robust
methods for full length sequencing of PRRSV directly from infected
tissues using next generation sequencing platforms. The protocols
generated sequences with the expected lengths and quality as illus-
trated by the preliminary phylogenetic analysis which showed the
expected clustering of the analyzed isolates. Further analyses of the
full genome sequences are in progress.
The protocols described in the present study were based on the
generation of long range PCR products using a high ﬁdelity poly-
merase which has a low error-rate. This high ﬁdelity polymerase
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s a mixture of recombinant Taq DNA polymerase, Pyrococcus
pecies GB-D polymerase, and Platinum Taq Antibody which results
n a nine-fold increase in ﬁdelity. Furthermore, this enzyme
lend is effective over a wide range of target sizes up to 20 kb
ith some optimization (http://tools.invitrogen.com/content/sfs/
anuals/accuprimetaqhiﬁ man.pdf). The protocol describes the
equencing of PCR amplicons covering the PRRSV genome in two
nd four fragments. Sequencing from two fragments has the advan-
age, besides the reduced labor handling only two amplicons, that
nly one sequence overlap will occur and less mismatch/bias from
he primer sequencing will be incorporated in the PCR amplicons
s only two primer pairs are used in the production of two PCR
mplicons. On the other hand, the disadvantage when amplifying
he PCR genome in two PCR fragments was that the concentra-
ion of the speciﬁc PCR amplicons often was of low concentration
s they often needed to be extracted from the gel instead of direct
uriﬁcation from the PCR mix  due to the present of unspeciﬁc prod-
cts. The advantage of sequencing from PCR amplicons covering the
RRSV genome in four fragments was that the PCR products were
f relatively high concentrations and speciﬁcity hence the ampli-
ons could be puriﬁed directly from the PCR mix  without the need
or gel puriﬁcation. The disadvantage of sequencing on four frag-
ents is that two sites of overlapping sequences will occur. The
equence primer bias is not problematic when sequencing is per-
ormed to obtain a consensus sequence for phylogenetic and amino
cid analyses, but should be kept in mind if the PCR products are
equenced for quasispecies and de novo analyses.
The main advantage of this method is that it enables viral RNA
xtracted directly from the primary material to be used as tem-
late for the cDNA synthesis. Such an approach bypasses the needs
or propagation of PRRSV in cell culture which can be tedious and
ime-consuming. The use of primary material for sequencing fur-
hermore prevents the introduction of mutations caused by cell
ulture adaptation and maintains the original level of quasispecies
istribution. This new, innovative method offers a tool for a faster
nd quicker production of full genome PRRSV sequences com-
ared to previous published protocol (Darwich et al., 2011; Van
oorsselaere et al., 2011).
Since only one NGS platform is available on most institutions,
he applicability of the methods described here is tempting because
ll three tested NGS platforms were shown to generate PRRSV
equences of satisfactory quality. The selection of the optimal plat-
orm should be based on a variety of considerations including price,
un time, read lengths, depth of coverage (yield data output). In
he present set-up, the coverage depth was considerably higher
or the Illumina HiSeq2000 compared to Roche 454 FLX and Ion
orrent PGM sequencer. Since PRRSV has a relative short genome
f 15 kb, the coverage depth obtained in this study from all three
GS platforms was satisfying. The run time for Illumina HiSeq2000
as 11 days compared to the run time for Roche 454 FLX and Ion
orrent PGM sequencer of 10 and 2 h respectively. The short run
imes give these latter two platforms an advantage in applications
here a fast result is crucial. For de novo assembly, read lengths
hould be a factor to consider. In this study, 37 bp read lengths were
btained from the Illumina and reads from the Roche 454 FLX and
on Torrent PGM sequencer were trimmed to major read lengths
f 450 and 170 bp, respectively. The reads were mapped using a
eference sequence and therefore the short read length was not a
roblem.
In conclusion, the long-range PCR protocols of the present
tudy offer a robust, cheap and fast method for the genera-
ion of full length PRRSV sequences directly from serum, tissues
nd cell cultures. The results of this work will be an added
alue for the development of new diagnostics and vaccine
esigns.al Methods 193 (2013) 697– 705
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